Loomba R, Abdelmalek MF, Armstrong MF et al (2022) Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
Contact us learn more or schedule a consultation to get started today
(Expert opinion varies over what degree of legal risk if any physicians face for prescribing peptides like BPC-157
Journal of Agriculture and Food Chemistry, 55 , 83398345
Ask about: Which medication class your provider recommends given your specific situation What your insurance covers and what the out-of-pocket costs will be What monitoring will be required (blood work, pregnancy tests, heart rate checks) What the plan is if the first medication does not work How long treatment should continue SeekPeptides members access comprehensive medication comparison tools, detailed protocol guides, and community discussions that help inform these conversations with healthcare providers
According to researchers from Mayo Clinic, nearly 9 out of every 10 people can expect to lose at least 5% of their body weight after taking semaglutide (Ozempic) for six months, and about half will lose 10% or more